We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Fully Automated Platform Designed for High-Throughput Genomic Cytometric Screening

By LabMedica International staff writers
Posted on 02 Nov 2009
A customized, innovative automated flow cytometry screening system has been developed for cell-based screening of small molecule compound libraries, RNAi libraries, and functional genomics applications.

The Agilent Automation Solutions' (Santa Clara, Ca, USA) fully automated platform consists of an IntelliCyt HyperCyt high-throughput flow cytometry (HTFC) platform combined with two Beckman Coulter (Fullerton, CA, USA) Cyan flow cytometers and integrated into an Agilent BioCel 1200 sample preparation and plate handling robotic platform. More...
The automated system, as configured, performs a diverse set of tasks important for carrying out functional genomics screens (cell culture, transfections, infections, sample concentration, and high-throughput flow cytometry) with very good throughput and minimal manual manipulation.

The technical poster presented at Society of Biomolecular Sciences Conference (SBS 2009) in April 2009 in Lille, France, showed how a proof-of-principle functional genomics shRNAmir screen for inhibitors of TGF-ß1 signaling in MPC9A7 cells identified several important regulators of this pathway. shRNAmirs targeting known signaling proteins such as Alk5 were readily detected using the HTFC capabilities of this platform.

With the automation configuration presented in the technical poster, throughput of the HyperCyt HTFC platform was doubled compared to stand alone operation. Data analysis software associated with the Agilent BioCel 1200 allowed plate level statistics to be generated within minutes of a screening run. In addition to speed, the technology is shown to considerably reduce the amount of sample aspirated for each analysis, typically acquiring two µL per well with thousands to tens of thousands of cells in each sample.

From standalone units to fully integrated systems, Agilent Automation Solutions combines key sample preparation and creative walk-away automation approaches with personalized customer service to provide complete solutions for laboratories.

Related Links:

Agilent Automation Solutions
Beckman Coulter


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Modular Hemostasis Automation Solution
CN Track
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.